Please login to the form below

Not currently logged in
Email:
Password:

Patient

This page shows the latest Patient news and features for those working in and with pharma, biotech and healthcare.

Novartis scores CHMP backing for cholesterol drug Leqvio

Novartis scores CHMP backing for cholesterol drug Leqvio

Leqvio ( inclisiran) is a potential first-in-class treatment for high cholesterol in Europe for patients with hypercholesterolemia or mixed dyslipidemia. ... Earlier this year Novartis announced that it had teamed up with the NHS in the UK which will see

Latest news

  • WHO trial casts doubt on remdesivir's efficacy WHO trial casts doubt on remdesivir's efficacy

    In July, Gilead said that the drug reduced the risk of death by 62% in severely-ill COVID-19 patients. ... This figure came from a comparative analysis from the company’s phase 3 SIMPLE-Severe trial and a real-world retrospective cohort of patients

  • Galapagos mid-stage trial failure raises concerns for Gilead deal Galapagos mid-stage trial failure raises concerns for Gilead deal

    Galapagos and its development partner for GLPG1972 Servier announced that the drug failed to improve outcomes in the phase 2 ROCCELLA study of knee osteoarthritis patients and was also unable to ... The drug was tested as three different once-daily oral

  • Novartis’ MS therapy Mayzent approved by NICE Novartis’ MS therapy Mayzent approved by NICE

    Novartis’ drug was first approved by the US Food and Drug Administration (FDA) in 2019 to delay disease progression in patients with SPMS. ... In clinical studies of Mayzent, the use of the drug was associated with statistically significant reductions

  • Lilly buys biotech firm Disarm Therapeutics for $135m Lilly buys biotech firm Disarm Therapeutics for $135m

    The ultimate aim will be to develop breakthrough treatment for patients with peripheral neuropathy and other neurological disease, including multiple sclerosis and amyotrophic lateral sclerosis (ALS). ... trial. The anti-amyloid candidate, solanezumab,

  • Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020 Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020

    much we value those individuals, teams, Trusts and partnerships who strive to improve the  quality of care and support provided to their patients with diabetes. ... 7. Patient Care Pathway, Secondary and Community. Cardiometabolic Care: A Pharmacist

More from news
Approximately 206 fully matching, plus 6,142 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 94 fully matching, plus 904 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 477 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 299 fully matching, plus 1,015 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

How community outreach can help improve diversity in clinical research
To execute a considered community engagement strategy, an involved and collaborative process is needed....
OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
...
Can eLearning improve patient recruitment and retention?
Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone....

Infographics